Rate My Professor Andrew Jamieson

Professor Andrew Jamieson is Professor of Chemical Biology in the School of Chemistry at the University of Glasgow. Born in Glasgow and raised in Strathaven, Scotland, he obtained a first-class BSc Honours degree in Chemistry with Medicinal Chemistry from the University of Glasgow in 2003. He completed his PhD there in 2007 under the supervision of Dr. Andrew Sutherland, investigating a substrate-directed palladium-catalysed aza-Claisen rearrangement and its application to natural product synthesis. Jamieson then pursued postdoctoral research, first as a fellowship with Professor William Lubell at the University of Montreal, Canada, in 2007, where he developed methods to scan peptides for secondary structure, focusing on bioactive conformations of GHRP-6 and rytvela. In 2008, he joined Professor Andrew Hamilton FRS at Yale University, USA, working on peptide beta-strand mimetics, and continued this collaboration at the University of Oxford, UK, in 2009. In August 2010, he was appointed Lecturer in the Centre for Chemical Biology, Department of Chemistry, at the University of Leicester. He returned to the University of Glasgow as Senior Lecturer in Chemical Biology in the School of Chemistry in July 2016, advanced to Reader in 2019, and was promoted to Professor in August 2022. In 2022, he co-founded Keltic Pharma Therapeutics Ltd. with University of Glasgow colleagues to develop curative treatments for Plasmodium falciparum malaria and GPCR-targeted therapies using the PEPSMOL platform.